We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.8B
AUM Growth
+$1.26B
(+2.4%)
Cap. Flow
-$756M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
2,394
New
190
Increased
762
Reduced
1,027
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$173M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$143M |
| 3 |
Blue Owl Capital
OWL
|
+$142M |
| 4 |
Conagra Brands
CAG
|
+$136M |
| 5 |
Lockheed Martin
LMT
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$215M |
| 2 |
PepsiCo
PEP
|
+$200M |
| 3 |
IBM
IBM
|
+$181M |
| 4 |
Merck
MRK
|
+$123M |
| 5 |
TSMC
TSM
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.62% |
| 2 | Technology | 19.5% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Globus Medical
GMED
$10.1B
| $1.25M | ﹤0.01% |
17,264
+200
| +1% | +$14.5K |
|
1202
BioMarin Pharmaceuticals
BMRN
$12.7B
| $1.24M | ﹤0.01% |
14,017
+8,943
| +176% | +$738K |
|
1203
Emcor
EME
$32.4B
| $1.23M | ﹤0.01% |
9,681
-1,007
| -9% | -$125K |
|
1204
Cullen/Frost Bankers
CFR
$9.95B
| $1.23M | ﹤0.01% |
9,771
+1,289
| +15% | +$166K |
|
1205
Insperity
NSP
$1.92B
| $1.23M | ﹤0.01% |
10,410
+849
| +9% | +$100K |
|
|
FLG
1206
Flagstar Bank National Association
FLG
$5.29B
| $1.23M | ﹤0.01% |
33,534
+4,874
| +17% | +$186K |
|
1207
NiSource
NI
$19.6B
| $1.23M | ﹤0.01% |
44,442
-14,956
| -25% | -$380K |
|
1208
Vontier
VNT
$4.3B
| $1.22M | ﹤0.01% |
39,648
+4,953
| +14% | +$161K |
|
1209
EQT Corp
EQT
$31.4B
| $1.22M | ﹤0.01% |
55,806
+10,586
| +23% | +$221K |
|
1210
Altria Group
MO
$116B
| $1.21M | ﹤0.01% |
25,480
+13,578
| +114% | +$622K |
|
1211
Acco Brands
ACCO
$402M
| $1.2M | ﹤0.01% |
145,512
-9,189
| -6% | -$79.1K |
|
1212
Encompass Health
EHC
$12.2B
| $1.2M | ﹤0.01% |
23,115
+818
| +4% | +$42.2K |
|
1213
Essent Group
ESNT
$6.12B
| $1.2M | ﹤0.01% |
26,268
+814
| +3% | +$37.3K |
|
1214
Labcorp
LH
$26.3B
| $1.19M | ﹤0.01% |
4,421
+1,233
| +39% | +$305K |
|
|
X
1215
DELISTED
US Steel
X
| $1.19M | ﹤0.01% |
49,929
+1,388
| +3% | +$32.7K |
|
|
OTRK
1216
DELISTED
Ontrak
OTRK
| $1.18M | ﹤0.01% |
2,088
+1,473
| +240% | +$1.03M |
|
1217
Prosperity Bancshares
PB
$8.51B
| $1.18M | ﹤0.01% |
16,332
-1,424
| -8% | -$105K |
|
1218
MP Materials
MP
$8.94B
| $1.18M | ﹤0.01% |
+25,914
| New | +$1.02M |
|
1219
Independent Bank Corp
IBCP
$814M
| $1.17M | ﹤0.01% |
49,097
| – | – |
|
|
SNBR
1220
DELISTED
Sleep Number
SNBR
| $1.17M | ﹤0.01% |
15,248
-3
| -0% | -$251 |
|
1221
Mid-America Apartment Communities
MAA
$14.2B
| $1.16M | ﹤0.01% |
5,071
+946
| +23% | +$196K |
|
1222
Mondelez International
MDLZ
$79B
| $1.16M | ﹤0.01% |
17,463
-992
| -5% | -$61.2K |
|
1223
Valvoline
VVV
$3.47B
| $1.16M | ﹤0.01% |
31,017
-875
| -3% | -$30.5K |
|
|
REVG
1224
DELISTED
REV Group
REVG
| $1.15M | ﹤0.01% |
81,559
-15
| -0% | -$237 |
|
1225
Texas Roadhouse
TXRH
$11B
| $1.15M | ﹤0.01% |
12,916
-405
| -3% | -$36.1K |
|
Similar funds
Federated Hermes's Q4 2021 Portfolio in Review
As of Q4 2021, Federated Hermes held 2,394 positions worth $53.8B, up 2.4% from $52.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q4 2021 filing shows 190 new, 762 increased, 1,027 reduced and 198 closed positions. Its largest new stake was Conagra Brands: 4,144,058 shares worth $142M. The largest sale was Moderna, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q4 2021 buy was Conagra Brands: 4,144,058 shares worth $142M.
- Federated Hermes added most to Bristol-Myers Squibb in Q4 2021, an estimated $173M increase.
- Federated Hermes's biggest Q4 2021 reduction was Moderna, cutting an estimated $215M.
- Federated Hermes fully exited GoDaddy in Q4 2021, selling an estimated $77.2M.
- Federated Hermes's ten largest holdings make up 13% of its $53.8B portfolio in Q4 2021.
- Federated Hermes opened 190 new positions and closed 198 in Q4 2021.
- Federated Hermes's portfolio value rose 2.4% quarter-over-quarter to $53.8B.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.